Top 100 Stocks by R&D Spending
Top companies ranked by R&D spending, latest annual filings.
What R&D Spending Means for US-listed Companies
R&D spending is the dollars a company puts into research, engineering, and product development each year. Under US GAAP most of it is expensed immediately rather than capitalized, so the outlay lands on the income statement in the year it is incurred and suppresses current earnings even when the work is building assets that will pay off over many future periods. Disclosure quality varies sharply across industries.
Why R&D Spending Matters
Sustained R&D is often what separates firms with a durable competitive moat from those slowly losing share to better-funded rivals, because patent pipelines, platform expansion, and technology leadership are cumulative. Still, R&D spending is not R&D productivity; two firms can commit similar dollars and produce very different pipelines. Timing also distorts cross-sector comparisons, since spike years on major programs look different from steady maintenance budgets.
What to Read Alongside
Read R&D alongside Revenue to gauge innovation intensity as a share of sales, Net Income to see how heavily expensing pressures earnings, and Free Cash Flow since R&D-heavy firms often show lower cash conversion.
| # | Symbol | Company | Sector | ||
|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc. | Communication Services | $61.09B | $3.41T |
| 2 | META | Meta Platforms, Inc. | Communication Services | $57.37B | $1.58T |
| 3 | AAPL | Apple Inc. | Technology | $45.77B | $5.11T |
| 4 | MSFT | Microsoft Corporation | Technology | $35.56B | $3.76T |
| 5 | NVDA | NVIDIA Corporation | Technology | $18.50B | $3.75T |
| 6 | MRK | Merck & Co., Inc. | Healthcare | $15.79B | $353.44B |
| 7 | JNJ | Johnson & Johnson | Healthcare | $14.66B | $670.92B |
| 8 | AZN | AstraZeneca PLC | Healthcare | $14.23B | $282.69B |
| 9 | INTC | Intel Corporation | Technology | $13.77B | $293.23B |
| 10 | LLY | Eli Lilly and Company | Healthcare | $13.34B | $1.26T |
| 11 | NVS | Novartis AG | Healthcare | $11.20B | $300.54B |
| 12 | AVGO | Broadcom Inc. | Technology | $10.98B | $1.63T |
| 13 | PFE | Pfizer Inc. | Healthcare | $10.44B | $162.27B |
| 14 | ORCL | Oracle Corporation | Technology | $10.27B | $358.54B |
| 15 | QCOM | QUALCOMM Incorporated | Technology | $10.21B | $178.34B |
| 16 | GSK | GSK plc | Healthcare | $10.12B | $98.70B |
| 17 | BMY | Bristol-Myers Squibb Company | Healthcare | $9.95B | $125.40B |
| 18 | TM | Toyota Motor Corporation | Consumer Cyclical | $9.86B | $250.12B |
| 19 | HMC | Honda Motor Co., Ltd. | Consumer Cyclical | $9.68B | $43.89B |
| 20 | BABA | Alibaba Group Holding Limited | Consumer Cyclical | $9.65B | $215.56B |
| 21 | CSCO | Cisco Systems, Inc. | Technology | $9.56B | $374.45B |
| 22 | F | Ford Motor Company | Consumer Cyclical | $9.40B | $45.28B |
| 23 | SNY | Sanofi | Healthcare | $9.20B | $114.13B |
| 24 | ABBV | AbbVie Inc. | Healthcare | $9.10B | $517.59B |
| 25 | IBM | International Business Machines Corporation | Technology | $8.32B | $218.41B |
| 26 | NVO | Novo Nordisk A/S | Healthcare | $8.18B | $179.38B |
| 27 | AMD | Advanced Micro Devices, Inc. | Technology | $8.09B | $833.18B |
| 28 | TSM | Taiwan Semiconductor Manufacturing Company Limited | Technology | $7.86B | $1.87T |
| 29 | SAP | SAP SE | Technology | $7.78B | $256.82B |
| 30 | AMGN | Amgen Inc. | Healthcare | $7.27B | $247.70B |
| 31 | TSLA | Tesla, Inc. | Consumer Cyclical | $6.41B | $1.50T |
| 32 | CRM | Salesforce, Inc. | Technology | $5.99B | $160.09B |
| 33 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $5.85B | $99.08B |
| 34 | GILD | Gilead Sciences, Inc. | Healthcare | $5.80B | $211.18B |
| 35 | NOK | Nokia Oyj | Technology | $5.70B | $42.95B |
| 36 | MU | Micron Technology, Inc. | Technology | $5.65B | $806.05B |
| 37 | ASML | ASML Holding N.V. | Technology | $5.51B | $533.08B |
| 38 | ERIC | Telefonaktiebolaget LM Ericsson (publ) | Technology | $5.30B | $33.43B |
| 39 | SONY | Sony Group Corporation | Technology | $4.79B | $155.50B |
| 40 | TAK | Takeda Pharmaceutical Company Limited | Healthcare | $4.25B | $69.14B |
| 41 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $3.91B | $135.44B |
| 42 | BA | The Boeing Company | Industrials | $3.62B | $129.89B |
| 43 | AMAT | Applied Materials, Inc. | Technology | $3.57B | $277.15B |
| 44 | UBER | Uber Technologies, Inc. | Technology | $3.40B | $140.50B |
| 45 | NFLX | Netflix, Inc. | Communication Services | $3.39B | $245.07B |
| 46 | INTU | Intuit Inc. | Technology | $3.38B | $85.73B |
| 47 | TEAM | Atlassian Corporation | Technology | $3.27B | $35.51B |
| 48 | JD | JD.com, Inc. | Consumer Cyclical | $3.18B | $34.34B |
| 49 | DELL | Dell Technologies Inc. | Technology | $3.14B | $205.23B |
| 50 | MRNA | Moderna, Inc. | Healthcare | $3.13B | $83.68B |
| 51 | NOW | ServiceNow, Inc. | Technology | $2.96B | $96.42B |
| 52 | ABT | Abbott Laboratories | Healthcare | $2.94B | $181.35B |
| 53 | BIDU | Baidu, Inc. | Communication Services | $2.92B | $24.22B |
| 54 | XYZ | Block, Inc. | Technology | $2.91B | $47.94B |
| 55 | MDT | Medtronic plc | Healthcare | $2.87B | $130.88B |
| 56 | RTX | RTX Corporation | Industrials | $2.81B | $267.19B |
| 57 | ARM | Arm Holdings plc | Technology | $2.78B | $196.23B |
| 58 | WDAY | Workday, Inc. | Technology | $2.68B | $44.05B |
| 59 | PANW | Palo Alto Networks, Inc. | Technology | $2.55B | $253.24B |
| 60 | NTES | NetEase, Inc. | Communication Services | $2.53B | $76.59B |
| 61 | HPE | Hewlett Packard Enterprise Company | Technology | $2.52B | $61.18B |
| 62 | SNPS | Synopsys, Inc. | Technology | $2.48B | $83.46B |
| 63 | BNTX | BioNTech SE | Healthcare | $2.47B | $21.04B |
| 64 | LRCX | Lam Research Corporation | Technology | $2.38B | $263.66B |
| 65 | NXPI | NXP Semiconductors N.V. | Technology | $2.36B | $63.65B |
| 66 | PDD | PDD Holdings Inc. | Consumer Cyclical | $2.36B | $110.16B |
| 67 | ABNB | Airbnb, Inc. | Consumer Cyclical | $2.35B | $106.31B |
| 68 | DE | Deere & Company | Industrials | $2.31B | $175.05B |
| 69 | MELI | MercadoLibre, Inc. | Consumer Cyclical | $2.27B | $72.84B |
| 70 | TCOM | Trip.com Group Limited | Consumer Cyclical | $2.16B | $27.46B |
| 71 | CAT | Caterpillar Inc. | Industrials | $2.15B | $261.19B |
| 72 | ONC | BeOne Medicines AG | Healthcare | $2.15B | $47.21B |
| 73 | PG | The Procter & Gamble Company | Consumer Defensive | $2.10B | $398.01B |
| 74 | TXN | Texas Instruments Incorporated | Technology | $2.08B | $270.35B |
| 75 | MRVL | Marvell Technology, Inc. | Technology | $2.08B | $133.83B |
| 76 | BSX | Boston Scientific Corporation | Healthcare | $2.05B | $62.37B |
| 77 | INCY | Incyte Corporation | Healthcare | $2.05B | $24.27B |
| 78 | STM | STMicroelectronics N.V. | Technology | $2.04B | $39.51B |
| 79 | LMT | Lockheed Martin Corporation | Industrials | $2.00B | $136.37B |
| 80 | PHG | Koninklijke Philips N.V. | Healthcare | $2.00B | $29.22B |
| 81 | SNOW | Snowflake Inc. | Technology | $1.97B | $96.29B |
| 82 | HON | Honeywell International Inc. | Industrials | $1.81B | $69.49B |
| 83 | SNAP | Snap Inc. | Communication Services | $1.79B | $9.50B |
| 84 | BIIB | Biogen Inc. | Healthcare | $1.78B | $37.07B |
| 85 | ADI | Analog Devices, Inc. | Technology | $1.77B | $185.91B |
| 86 | COIN | Coinbase Global, Inc. | Financial Services | $1.67B | $30.45B |
| 87 | RIVN | Rivian Automotive, Inc. | Consumer Cyclical | $1.67B | $17.34B |
| 88 | ADSK | Autodesk, Inc. | Technology | $1.64B | $53.34B |
| 89 | EBAY | eBay Inc. | Consumer Cyclical | $1.64B | $52.06B |
| 90 | SPOT | Spotify Technology S.A. | Communication Services | $1.63B | $123.73B |
| 91 | SYK | Stryker Corporation | Healthcare | $1.62B | $120.88B |
| 92 | LI | Li Auto Inc. | Consumer Cyclical | $1.62B | $11.31B |
| 93 | GMAB | Genmab A/S | Healthcare | $1.61B | $32.04B |
| 94 | HPQ | HP Inc. | Technology | $1.60B | $25.89B |
| 95 | DHR | Danaher Corporation | Healthcare | $1.60B | $158.84B |
| 96 | GE | GE Aerospace | Industrials | $1.58B | $338.66B |
| 97 | RBLX | Roblox Corporation | Communication Services | $1.57B | $31.49B |
| 98 | DDOG | Datadog, Inc. | Technology | $1.55B | $59.64B |
| 99 | SHOP | Shopify Inc. | Technology | $1.54B | $182.56B |
| 100 | KLAC | KLA Corporation | Technology | $1.53B | $188.36B |
No companies match this search.
How this ranking is built
Companies are ranked by R&D spending as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals, and a company that files in another currency is ranked on its figures translated at the rate recorded for that period.
- Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, NYSE American, Texas Stock Exchange).
- Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
- Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
- Size floor: A company qualifies at $500 million in market cap or above. Below that, one mis-stated figure outranks the companies the list is about.
- Currency check: A company whose annual revenue runs above 15 times its market cap is left out, because at that gap the two figures are not in the same currency.
- Currency check: A company whose balance sheet runs above 150 times its market cap is left out for the same reason.
- Market cap: stated at each company's latest close, which is newer than the annual figure ranked here.
- Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).
Not financial advice. This is a research tool, not a recommendation.
Frequently asked questions
Why does R&D spending reduce reported earnings even when it builds long-term value?
US accounting rules require most research and development to be expensed in the period it is incurred, rather than capitalized and depreciated over the life of the resulting product. The logic is conservative: the future benefit is uncertain, so it would overstate assets to carry R&D on the balance sheet. The side effect is that a firm investing heavily in next-generation products can look less profitable than a peer harvesting an older portfolio, even if the long-term economics favor the investor.
Does a higher R&D figure mean a stronger innovation pipeline?
Not directly. Spending measures input, not output. Two firms can commit similar R&D dollars yet produce very different pipelines depending on research focus, execution quality, and the patience of management. Absolute dollars also favor larger firms by default, so the ratio of R&D to revenue often tells a more useful story about commitment to innovation than the raw total, and patent filings or product cadence add an independent check on how productive that spending actually is.
Why are some industries missing from R&D rankings?
Financial services, real estate, and parts of consumer retail tend not to disclose meaningful R&D, either because the expense category does not fit their activities or because equivalent spending appears under other lines such as technology investment or product development. The ranking therefore over-represents technology, healthcare, and parts of industrials where formal R&D disclosure is standard, and under-represents sectors where comparable innovation spending is real but reported differently.